MDM2 and neuroblastoma: These observations are consistent with previous studies showing that MYCN sensitises neuroblastoma cell lines to MDM2-p53 antagonists, Nutlin-3 and MI-63 [18], and p14ARF silencing leads to resistance to Nutlin-3 induced apoptosis [19].